Boryung eying sales of 100 billion won with new antihypertensive agent

Boryung Pharmaceutical Co., one of Korea's largest pharmaceutical companies, says it will launch its homegrown antihypertensive drug, Fimasartan, in March as its health insurance price is expected to be settled sooner or later.

The drug marks the 15th new medicine developed by a local drug manufacturer.

With an aim to raise 100 billion won in domestic sales within the next five years, the...